You searched for "stenosis"

289 results found

The 66th Hallpike Symposium - BAAP

The 66th Hallpike Symposium took place on the 15th November 2024. It was organised by Drs Carolyn Ainsworth and Rosa Crunkhorn, Audiovestibular Medicine (AVM) Consultants at Guy’s and St Thomas’ NHS Foundation Trust, London. The theme of the event was ‘Recognising systemic conditions associated with audiovestibular dysfunction for the practicing clinician’.

Outcomes of temporal bone-resurfacing for pulsatile tinnitus associated with vascular wall anomalies

This month’s Ed’s choice is an interesting systematic review into the management of pulsatile tinnitus. There are impressive results from resurfacing of symptomatic anatomical abnormalities of the temporal bone and I suspect that referrals for further imaging and otology clinic...

In memory of Iain Swan 1952–2025

Iain Swan. Iain Swan was a Senior Lecturer in Otorhinolaryngology, University of Glasgow and Consultant Otorhinolaryngologist, Glasgow Royal Infirmary and Scottish Section MRC Institute of Hearing Research 1986-2016. Iain had a happy childhood growing up in Carbeth and attended school...

The ENT operating theatre viewed down the retrospectoscope

We learn much of our future by looking at our past; Douglas MacMillan provides us with a fascinating glimpse into his years as a junior doctor. The operating theatre was a somewhat alien environment in the late 1960s: theatre sisters...

On the shoulders of giants: a reflection on Wolfgang Steiner

Professor Wolfgang Steiner. Wolfgang Steiner inspired a whole generation of head and neck surgeons. Terry Jones gives us his own personal perspective. “We are like dwarfs on the shoulders of giants, so that we can see more than they, and...

IL-25 and nasal polyps, another target

Immune response in chronic rhinosinusitis with nasal polyps (CRSwNP) is mainly via type 2 T-helper (Th2) cells while Th1 cells characterise chronic rhinosinusitis without nasal polyps (CRSsNP) immune response. CRSwNP is heterogeneous on a cytological level causing a varied response...

Recovery rates in sudden sensorineural hearing loss

Sudden sensorineural hearing loss (SSNHL) is most commonly idiopathic, and is seen relatively frequently in ENT practice. Recovery spans a period of around 1-2 months, and ultimate outcomes are highly variable, from complete recovery to no detectable hearing. Although the...

Allergen specific subcutaneous immunotherapy helps in prolonged control of allergic rhinitis

One of the commonest allergens involved in perennial allergic rhinitis is house dust mite. A good proportion of these cases prove intractable to treatment with oral and intranasal antihistamines and intranasal steroid sprays. Immunotherapy is considered a useful alternative and...

Effects of nasal sprays on ciliary function

What do topical nasal sprays do to the nasal mucosa in the long term? This study reports the effect of corticosteroids, antihistamines and common preservatives in nasal sprays, benzalkonium chloride (BKC) and potassium sorbate (PS), on an in-vitro model of...

Evidence and nasal polyp treatments

The change in the routine management of nasal polyps in the past 2-3 decades has been fascinating and this review from Charleston covers the topics of systemic treatment, local treatment, perioperative treatment and immunotherapy and touches on the lower airway...

Location, location, location: How to get the steroid where you need it, in chronic rhinosinusitis

What almost all current guidelines on chronic rhinosinusitis have in common is the importance of intranasal steroid (INCS) use. However, it is increasingly understood that the efficacy of INCS depends on their efficient delivery to the point of need, i.e....

Patients with auto-immune Meniere’s disease more likely to respond to intratympanic steroids

The authors retrospectively reviewed the duration of symptom control after intratympanic dexamethasone (IT) injections in 27 patients with Meniere’s disease (MD) over a six-year period. The patients received two IT injections of 3.3mg/ml of dexamethasone one-to-two weeks apart. Eleven patients...